Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
M Omata, AL Cheng, N Kokudo, M Kudo, JM Lee… - Hepatology …, 2017 - Springer
There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …
[HTML][HTML] Predictors of early and late hepatocellular carcinoma recurrence
R Nevola, R Ruocco, L Criscuolo, A Villani… - World journal of …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …
are constantly increasing. Despite the availability of potentially curative treatments (liver …
Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: a multi …
LQ Yao, ZL Chen, ZH Feng, YK Diao, C Li… - Annals of surgical …, 2022 - Springer
Background A potentially curative hepatic resection is the optimal treatment for
hepatocellular carcinoma (HCC), but most HCCs, even at an early stage, eventually recur …
hepatocellular carcinoma (HCC), but most HCCs, even at an early stage, eventually recur …
Percutaneous ablation for hepatocellular carcinoma: comparison of various ablation techniques and surgery
S Shiina, K Sato, R Tateishi, M Shimizu… - Canadian Journal of …, 2018 - Wiley Online Library
Image‐guided percutaneous ablation is considered best in the treatment of early‐stage
hepatocellular carcinoma (HCC). Ablation is potentially curative, minimally invasive, and …
hepatocellular carcinoma (HCC). Ablation is potentially curative, minimally invasive, and …
Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma
This article provides an overview of diagnostic evaluation and ablation treatment
assessment in Hepatocellular Carcinoma (HCC). Only studies, in the English language from …
assessment in Hepatocellular Carcinoma (HCC). Only studies, in the English language from …
A review of radiofrequency ablation: Large target tissue necrosis and mathematical modelling
Radiofrequency ablation (RFA) is an effective clinical method for tumour ablation with
minimum intrusiveness. However, the use of RFA is mostly restricted to small tumours …
minimum intrusiveness. However, the use of RFA is mostly restricted to small tumours …
Neoadjuvant and adjuvant systemic therapies in loco-regional treatments for hepatocellular carcinoma: are we at the dawn of a new era?
Simple Summary The treatment of hepatocellular carcinoma is burdened by an
unacceptable recurrence rate after loco-regional treatment. Unlike all other solid tumors, no …
unacceptable recurrence rate after loco-regional treatment. Unlike all other solid tumors, no …
Efficacy of hepatic resection vs. radiofrequency ablation for patients with very-early-stage or early-stage hepatocellular carcinoma: a population-based study with …
YQ Jiang, ZX Wang, YN Deng, Y Yang… - Frontiers in …, 2019 - frontiersin.org
Background: Because of the poor health conditions of elderly patients (age> 65) with very-
early-stage and early-stage hepatocellular carcinoma (HCC), primary treatment via hepatic …
early-stage and early-stage hepatocellular carcinoma (HCC), primary treatment via hepatic …
[HTML][HTML] Preoperative albumin-bilirubin score for postoperative solitary hepatocellular carcinoma within the milan criteria and Child-Pugh A cirrhosis
Surgical resection remains the initial treatment of choice for the majority of early stage
hepatocellular carcinoma (HCC) patients. Although the factors that influence the prognosis …
hepatocellular carcinoma (HCC) patients. Although the factors that influence the prognosis …
Radiofrequency ablation is an inferior option to liver resection for solitary hepatocellular carcinoma≤ 5 cm without cirrhosis: A population-based study with …
SC Dong, DS Bai, FA Wang, SJ Jin, C Zhang… - … & Pancreatic Diseases …, 2023 - Elsevier
Abstract Background About 10%-20% of all individuals who develop hepatocellular
carcinoma (HCC) do not have cirrhosis. Comparisons are rarely reported regarding the …
carcinoma (HCC) do not have cirrhosis. Comparisons are rarely reported regarding the …